Finance

Lists
Why is 002653 up 5.02%?
Dive Deeper
002653:SHE
Haisco Pharmaceutical Group Co Ltd
CNÂ¥59.00
+5.02%
(+2.82) 1D
Nov 4, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002653...
Open
CNÂ¥56.05
High
CNÂ¥59.51
Low
CNÂ¥55.59
Mkt. cap
64.10B
Avg. vol.
4.49M
Volume
6.08M
Dividend
1.12%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
Sep 4, 2026
P/E ratio
49.52
52-wk high
CNÂ¥80.83
52-wk low
CNÂ¥42.38
EPS
CNÂ¥1.19
Shares outstanding
1.14B
No. of employees
6K
Open
CNÂ¥56.05
High
CNÂ¥59.51
Low
CNÂ¥55.59
Mkt. cap
64.10B
Avg. vol.
4.49M
Volume
6.08M
Dividend
1.12%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
Sep 4, 2026
P/E ratio
49.52
52-wk high
CNÂ¥80.83
52-wk low
CNÂ¥42.38
EPS
CNÂ¥1.19
Shares outstanding
1.14B
No. of employees
6K
News stories
From web sources and news partners
About Haisco Pharmaceutical Group Co Ltd
CEO-
Employees5.6K
Founded2000
Headquarters-
SectorPharmaceutical industry
Industry-
Websitehaisco.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.09B
1.56B
1.53B
1.87B
Cost of goods sold
405.00M
290.96M
321.55M
359.30M
Cost of revenue
405.00M
290.96M
321.55M
359.30M
Research and development expenses
261.90M
225.24M
353.35M
332.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
590.48M
472.75M
581.09M
644.25M
Operating expense
859.43M
706.43M
951.23M
882.86M
Total operating expenses
1.26B
997.39M
1.27B
1.24B
Operating income
-176.78M
566.60M
258.83M
632.68M
Other non operating income
23.71M
-2.33M
1.64M
-6.29M
EBT including unusual items
-64.13M
592.93M
279.97M
537.66M
EBT excluding unusual items
-155.42M
565.01M
254.88M
656.18M
Income tax expense
-28.41M
38.33M
-16.64M
12.41M
Effective tax rate
44.30%
6.46%
-5.94%
2.31%
Other operating expenses
9.94M
10.01M
15.95M
-95.07M
Net income
-35.72M
554.61M
296.62M
525.25M
Net profit margin
-3.28%
35.46%
19.37%
28.02%
Earnings per share
-
-
-
-
Interest and investment income
6.36M
7.50M
9.97M
27.61M
Interest expense
-7.63M
-6.76M
-7.06M
-6.31M
Net interest expenses
-1.27M
741.96K
2.91M
21.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
-111.07M
632.30M
335.93M
698.39M
Gain or loss from assets sale
22.27M
-
-877.19K
877.19K
Upcoming events
AI content may include mistakes. Learn more
Google apps